Showing results (241-250 of 563) with videos related to
Sort By:
Pageof 57
Microbial Biotechnology|April 16, 2015
A preliminary and qualitative study of resource ratio theory to nitrifying lab-scale bioreactorsMicol Bellucci, Irina D Ofiţeru, Luciano Beneduce, et al.Circulation. Cardiovascular Quality and Outcomes|December 8, 2011
Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data RegistryJeptha P Curtis, Saif S Rathore, Yongfei Wang, et al.Clinical Therapeutics|May 13, 1999
Comparison of an orally disintegrating ondansetron tablet with the conventional ondansetron tablet for cyclophosphamide-induced emesis in cancer patients: a multicenter, double-masked study. Ondansetron Orally Disintegrating Tablet Emesis Study GroupN Davidson, B Rapoport, B Erikstein, et al.Journal of Aging and Health|December 17, 2004
Satisfaction with care among community residential care residentsMichael P Curtis, Anne E B Sales, Jean H Sullivan, et al.The American Journal of Cardiology|November 13, 2013
Prevalence, correlates, and temporal trends in antiarrhythmic drug use at discharge after implantable cardioverter defibrillator placement (from the National Cardiovascular Data Registry [NCDR])Sandesh Dev, Pamela N Peterson, Yongfei Wang, et al.Water Research|December 3, 2014
Flow cytometric quantification of viruses in activated sludgeM R Brown, S Camézuli, R J Davenport, et al.Microbiology Spectrum|February 20, 2024
Effects of glucose and lactate on Streptococcus mutans abundance in a novel multispecies oral biofilm modelJay S Sangha, Paul Barrett, Thomas P Curtis, et al.British Journal of Clinical Pharmacology|March 16, 2000
Single dose methodology to assess the influence of an alpha1-adrenoceptor antagonist on uroflowmetric parameters in patients with benign prostatic hyperplasiaS P Curtis, I Eardley, M Boyce, et al.The American Journal of Cardiology|November 6, 2017
Coronary Venous Dissection from Left Ventricular Lead Placement During Cardiac Resynchronization Therapy With Defibrillator Implantation and Associated in-Hospital Adverse Events (from the NCDR ICD Registry)Jonathan C Hsu, Paul D Varosy, Haikun Bao, et al.BMC Musculoskeletal Disorders|December 3, 2005
Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]Sean P Curtis, Barry Bockow, Chester Fisher, et al.Pageof 57